Neurocrine Biosciences logo

Neurocrine Biosciences dividend yield (ttm)NASDAQ: NBIX

Dividend yield (TTM)

-

25 October 2024

Performance
Most recent-
1 year-
3 years-
5 years-

Add series to chart

(max: 6)
company, ETF, index, featured screener or watchlist
series name

Suggested series

Dividend yield (TTM) performance

Most recent change
NBIX-
FMS+4.3%
RPRX+1.6%
ATR-1.0%
TECH-2.1%
SNN+4.7%
1 year change
NBIX-
RPRX+7.3%
ATR-20.9%
TECH-11.5%
SNN-22.2%
3 years change
NBIX-
FMS+37.1%
RPRX+76.6%
ATR-12.1%
TECH+84.0%
SNN+26.7%
5 years change
NBIX-
FMS+57.0%
ATR-14.3%
TECH-27.0%
SNN+59.3%

Dividend yield (TTM) performance

NBIXFMSRPRXATRTECHSNNINSM
Most recent-+4.3%+1.6%-1.0%-2.1%+4.7%-
1 year--+7.3%-20.9%-11.5%-22.2%-
3 years-+37.1%+76.6%-12.1%+84.0%+26.7%-
5 years-+57.0%--14.3%-27.0%+59.3%-
FAQ

What is Neurocrine Biosciences dividend yield (ttm)?

Neurocrine Biosciences dividend yield (ttm) is

How has Neurocrine Biosciences dividend yield (ttm) changed over the year?

Over the past year, Neurocrine Biosciences dividend yield (ttm) has not changed. During the same period, , Royalty Pharma has risen by 7.3%, AptarGroup has gone down by 20.9%, Bio-Techne has dropped by 11.5%, Smith & Nephew has decreased by 22.2%

How has Neurocrine Biosciences dividend yield (ttm) changed over the 3 years?

During the last 3 years, Neurocrine Biosciences dividend yield (ttm) has not changed. Over the same period, Fresenius Medical Care AG & Co KGaA has increased by 37.1%, Royalty Pharma has risen by 76.6%, AptarGroup has gone down by 12.1%, Bio-Techne has increased by 84.0%, Smith & Nephew has risen by 26.7%

How has Neurocrine Biosciences dividend yield (ttm) changed over the 5 years?

For the past 5 years, Neurocrine Biosciences dividend yield (ttm) has not changed. In the same period, Fresenius Medical Care AG & Co KGaA has increased by 57.0%, AptarGroup has gone down by 14.3%, Bio-Techne has dropped by 27.0%, Smith & Nephew has risen by 59.3%